ATHA – athira pharma, inc. (US:NASDAQ)

News

Athira Pharma Reports Third Quarter 2025 Financial Results and Provides Business Update
Athira Pharma (NASDAQ:ATHA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Athira Pharma (NASDAQ:ATHA) was given a new $4.00 price target on by analysts at Mizuho.
Athira Pharma Announces Reverse Stock Split [Yahoo! Finance]
Athira Pharma Announces Reverse Stock Split
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com